Pembrolizumab (Keytruda), an immune checkpoint inhibitor, has been increasingly utilized in the treatment of metastatic urothelial carcinoma. While offering a favorable safety profile compared to traditional chemotherapy, it presents unique risks, including immune-related adverse events (irAEs). This case report describes a 77-year-old woman with a history of invasive bladder cancer treated with pembrolizumab who developed severe bilateral ptosis, myositis, and myocarditis.
View Article and Find Full Text PDFObstructive sleep apnea (OSA) is a sleep-related breathing disorder associated with obesity markers such as neck circumference (NC), waist circumference (WC), and body mass index (BMI). A greater NC has been linked to a higher risk of OSA. To date, the largest reported NC has been 20.
View Article and Find Full Text PDFIntroduction: Antimicrobial resistance (AMR) is an emerging global threat. It increases mortality and morbidity and strains healthcare systems. Health care professionals can counter the rising AMR by promoting antibiotic stewardship and facilitating new drug development.
View Article and Find Full Text PDF